TriNutra was formed with a vision to serve unmet health needs with formulations possessing immediate action and efficacy. It has created an innovative approach to product development, focusing on synergistic relationships between ingredients for optimal efficacy, proper therapeutic dosages, and extensive clinical research to support the efficacy of ingredient combinations. After multiple years of joint research and development work with Nigella sativa oil, TriNutra released the first vertically integrated and standardized cold-pressed Nigella sativa oil in the US, standardized to 3% thymoquinone with low free fatty acids. TriNutra's ThymoQuin has also met the USP monograph and is backed by multiple patents.